Institutional investors hold a majority ownership of MYGN through the 138.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2013, these large investors purchased a net $22.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 3.7 Million shares of Myriad Genetics Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.0 Million shares of Myriad Genetics Inc
MUNDER CAPITAL MANAGEMENT, INC. Bought 3.0 Million shares of Myriad Genetics Inc